The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

Share Price Information for De La Rue (DLAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.00
Bid: 90.20
Ask: 92.60
Change: 0.60 (0.67%)
Spread: 2.40 (2.661%)
Open: 88.80
High: 91.60
Low: 88.00
Prev. Close: 89.40
DLAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Oct 2020 07:00

RNS Number : 1289C
De La Rue PLC
15 October 2020
 

15 October 2020

 

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue") today announces a trading update for the six months ended 26 September 2020.

Trading for the financial year 2020/21 to date has been positive, with revenue and adjusted operating profit for the first half in line with the Board's expectations. Net debt at the half year was lower than expected due mainly to the phasing of capital expenditure and positive working capital movements. Net debt for the full year is forecast to be in line with the Board's expectations.

De La Rue expects to announce its results for the six months ended 26 September 2020 on 25 November 2020.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

Enquiries:

De La Rue plc

 

+44 (0) 7387 122645

 

Clive Vacher

 

Chief Executive Officer

 

Rob Harding

 

Chief Financial Officer

 

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

 

 

 

 

Brunswick

 

+44 (0)207 404 5959

 

Stuart Donnelly

 

Imran Jina

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "goal", "target", "aim", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, profitability, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

 

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond De La Rue's ability to control or predict. Forward-looking statements are not guarantees of future performance. The Group's actual results of operations, profitability, financial condition, liquidity, prospects, growth and/or strategy and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, profitability, financial condition, liquidity, prospects, growth and/or strategy of the Group and the development of the industry in which it operates are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

 

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMMGNDNGGZM
Date   Source Headline
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSDirectorate Change
4th Aug 20237:00 amRNSDirectorate Change
3rd Aug 20239:21 amRNSAppointment of Joint Broker
2nd Aug 20233:26 pmRNSDirector/PDMR Shareholding
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 20231:44 pmRNSDirector/PDMR Shareholding
24th Jul 20233:04 pmRNSHolding(s) in Company
20th Jul 20234:03 pmRNSHolding(s) in Company
20th Jul 202312:17 pmRNSAnnual Financial Report
19th Jul 20231:01 pmRNSHolding(s) in Company
11th Jul 202310:28 amRNSDirector/PDMR Shareholding
4th Jul 202312:59 pmRNSHolding(s) in Company
3rd Jul 20235:44 pmRNSHolding(s) in Company
3rd Jul 202312:12 pmRNSBlock listing Interim Review
3rd Jul 202312:09 pmRNSTotal Voting Rights
30th Jun 20231:40 pmRNSHolding(s) in Company
30th Jun 20231:35 pmRNSHolding(s) in Company
30th Jun 202310:11 amRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSFY23 full year results
28th Jun 20235:25 pmRNSHolding(s) in Company
28th Jun 20231:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.